USE OF SYNERGISTIC COMBINATIONS OF A NK 1? RECEPTOR ANTAGONIST AND A GABA ANALOG IN PSYCHIATRIC DISORDERS - Patent 1233766

(19)

(11)

EP 1 233 766 A1

(12)

(43)	Date of publication:
	28.08.2002 Bulletin 2002/35

(21)	Application number: 00979495.9

(22)	Date of filing: 09.10.2000

(51)	International Patent Classification (IPC)⁷: A61K 31/195, A61K 31/404, A61K 31/40, A61P 25/18, A61P 25/24, A61K 45/06 // A61K31:40, A61K31:195

(86)	International application number:
	PCT/EP0010/084

(87)	International publication number:
	WO 0102/4791 (12.04.2001 Gazette 2001/15)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

07.10.1999 US 158271 P

(71)	Applicant: WARNER-LAMBERT COMPANY
	Morris PlainsNew Jersey 07950 (US)

(72)	Inventors:
	Hughes, John Swaffham Bulbeck, Cambridgeshire CB5 ONF (GB) Singh, Lakhbir Ely, Cambridgeshire CB7 3SP (GB)

(74)	Representative: Hirsch, Denise et al
	Pfizer SCA,Fresnes Laboratories,3-9, rue de la Loge,B.P. 100 94265 Fresnes Cedex 94265 Fresnes Cedex (FR)

(54)	USE OF SYNERGISTIC COMBINATIONS OF A NK 1? RECEPTOR ANTAGONIST AND A GABA ANALOG IN PSYCHIATRIC DISORDERS